Beta Trace Protein as a Potential Biomarker for CSF-Venous Fistulas.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
24 Aug 2024
Historique:
received: 15 05 2024
accepted: 14 08 2024
medline: 26 8 2024
pubmed: 26 8 2024
entrez: 24 8 2024
Statut: aheadofprint

Résumé

Accurately identifying patients with CSF-venous fistulas (CVF), one cause of spontaneous intracranial hypotension (SIH), is a diagnostic dilemma. This conundrum underscores the need for a CVF biomarker to help select who should undergo an invasive myelogram for further diagnostic workup. Beta trace protein (BTP) is the most abundant CNS derived protein in the CSF and therefore is a potential venous biomarker for CVF detection. The purpose of our study was to measure venous BTP levels as a potential CVF biomarker. We prospectively enrolled 14 patients with CVF and measured BTP in venous blood samples from the paraspinal veins near the CVF and compared those levels to the peripheral blood. Myelograms used initially to identify the CVF were evaluated for modality, CVF laterality, CVF level, and venous drainage pattern. Patient sex, patient age, and symptom duration were also collected. Brain MR images were reviewed for Bern scores. We also measured the peripheral blood BTP levels in 20 normal controls. In patients with CVF, the mean BTP level near the CVF was 54.5% higher (0.760 [SD 0.673] vs 0.492 [SD 0.095] mg/L; p = 0.069) compared to peripheral blood. Nine (64.3%) patients with CVF had a higher paraspinal BTP level than peripheral BTP level. The 20 control patients had a higher the mean peripheral BTP level 0.720 (SD 0.191) mg/L compared to patients with CVF (p<0.001). We found that venous blood at the site of CVF had higher BTP values compared to peripheral blood in the majority, but not all patients with CVF. This may reflect the intermittent leaking nature of CVF. Additionally, we found that patients with CVF had a lower peripheral blood BTP level compared to normal controls. BTP requires further evaluation as a potential CVF biomarker. SIH = Spontaneous Intracranial Hypotension; CVF = CSF-Venous Fistula; CTM = CT myelogram; DSM = Digital Subtraction Myelography; BTP = Beta Trace Protein.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Accurately identifying patients with CSF-venous fistulas (CVF), one cause of spontaneous intracranial hypotension (SIH), is a diagnostic dilemma. This conundrum underscores the need for a CVF biomarker to help select who should undergo an invasive myelogram for further diagnostic workup. Beta trace protein (BTP) is the most abundant CNS derived protein in the CSF and therefore is a potential venous biomarker for CVF detection. The purpose of our study was to measure venous BTP levels as a potential CVF biomarker.
MATERIALS AND METHODS METHODS
We prospectively enrolled 14 patients with CVF and measured BTP in venous blood samples from the paraspinal veins near the CVF and compared those levels to the peripheral blood. Myelograms used initially to identify the CVF were evaluated for modality, CVF laterality, CVF level, and venous drainage pattern. Patient sex, patient age, and symptom duration were also collected. Brain MR images were reviewed for Bern scores. We also measured the peripheral blood BTP levels in 20 normal controls.
RESULTS RESULTS
In patients with CVF, the mean BTP level near the CVF was 54.5% higher (0.760 [SD 0.673] vs 0.492 [SD 0.095] mg/L; p = 0.069) compared to peripheral blood. Nine (64.3%) patients with CVF had a higher paraspinal BTP level than peripheral BTP level. The 20 control patients had a higher the mean peripheral BTP level 0.720 (SD 0.191) mg/L compared to patients with CVF (p<0.001).
CONCLUSIONS CONCLUSIONS
We found that venous blood at the site of CVF had higher BTP values compared to peripheral blood in the majority, but not all patients with CVF. This may reflect the intermittent leaking nature of CVF. Additionally, we found that patients with CVF had a lower peripheral blood BTP level compared to normal controls. BTP requires further evaluation as a potential CVF biomarker.
ABBREVIATIONS BACKGROUND
SIH = Spontaneous Intracranial Hypotension; CVF = CSF-Venous Fistula; CTM = CT myelogram; DSM = Digital Subtraction Myelography; BTP = Beta Trace Protein.

Identifiants

pubmed: 39181694
pii: ajnr.A8476
doi: 10.3174/ajnr.A8476
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 by American Journal of Neuroradiology.

Auteurs

Ian T Mark (IT)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Waleed Brinjikji (W)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Jeremy Cutsforth-Gregory (J)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Jared T Verdoorn (JT)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

John C Benson (JC)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Ajay A Madhavan (AA)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Jeff W Meeusen (JW)

From the Department of Radiology (I.T.M., W.B., J.T.V, J.C.B, A.A.M.), Department of Neurology (J.C-G), and Department of Laboratory Medicine and Pathology (J.W.M.), Mayo Clinic, Rochester, MN, USA.

Classifications MeSH